A breakthrough for CanSino Biologics, Inc., being the first local vaccine company of the province of China to be approved of a patent to a Novel coronavirus or COVID-19 vaccine, Reuters said. State media, People’s Daily, reported last Sunday, August 17, 2020, that CanSino Biologics, Inc., a Chinese biopharmaceutical firm, has been approved by China...
by Eric Hamilton, University of Wisconsin-Madison University of Wisconsin-Madison scientists have discovered that a majority of back-pain patients they tested who were taking opioid painkillers produced anti-opioid antibodies. These antibodies may contribute to some of the negative side effects of long-term opioid use. Existing antibodies may also limit the benefit a patient receives from an...
by James Cook University A study of older mice with type 2 diabetes has yielded highly promising results for researchers investigating potential new vaccines for tuberculosis (TB). A team of researchers from Australia, Bangladesh and France investigated a potential vaccine, BCG::RD1, and found it highly protective when administered directly into the lungs of diabetic mice,...
by Columbia University Irving Medical Center Cryo-EM reconstructions show how two different antibodies (blue) bind to the spike protein of the SARS-CoV-2 virus. Credit: David Ho / Columbia University Irving Medical Center Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in...
by Albert Einstein College of Medicine To study the potentially lethal coronavirus, Albert Einstein College of Medicine scientists have turned a relatively harmless virus into a coronavirus “surrogate” that is much safer to work with. The research was described this month in Cell Host & Microbe. “Research on the ‘real’ coronavirus is limited by the...
The race for a vaccine against the novel coronavirus, or SARS-CoV-2, is on, with 54 different vaccines under development, two of which are already being tested in humans, according to the World Health Organization. And among the different candidates is a new player on the scene – mRNA vaccines. According to Prof. Bekeredjian-Ding, an approved...
Issued on: 04/07/2020 – 11:50 India’s topmost medical research body said that it is attempting to launch the world’s first Covid-19 vaccine on August 15. However, health experts have questioned the short timeline. ADVERTISING The order by Balram Bhargava, director general of the Indian Council of Medical Research (ICMR) on Friday directs 12 hospitals selected...
Inaccurate: RNA from a vaccine would not be able to directly alter our DNA, in part because of the chemical differences between the two nucleic acids. RNA also would not persist long enough to cause autoimmunity. Autoimmune diseases are chronic in nature, whereas RNA has a very short lifespan, being quickly degraded after it has...
OHSU research targets disease afflicting millions in developing world OREGON HEALTH & SCIENCE UNIVERSITY Scientists at Oregon Health & Science University have teamed up with OHSU spinoff, Najít Technologies, Inc. to develop a new vaccine that appears to confer immunity to a diarrheal disease that afflicts hundreds of millions of people in developing countries around...
CLAIM Vaccinated children are more likely to have adverse health outcomes like developmental delays, asthma, and ear infections compared to unvaccinated children. VERDICT SOURCE: Brian Hooker, Children’s Health Defense, 28 May 2020 DETAILS Inadequate support: This claim is based on a single study which used highly biased methods. Rigorous and large-scale studies have not found...
